Real-time Estimate
Cboe Europe
06:48:43 2024-06-10 am EDT
|
5-day change
|
1st Jan Change
|
72.58
SEK
|
-0.24%
|
|
+0.28%
|
+37.93%
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Capitalization
1 |
7,419
|
6,148
|
5,715
|
4,161
|
4,711
|
6,297
|
-
|
-
|
Enterprise Value (EV)
1 |
15,336
|
14,524
|
15,536
|
14,879
|
15,450
|
16,965
|
16,606
|
15,600
|
P/E ratio
|
31.2
x
|
17.1
x
|
24.1
x
|
11.3
x
|
10.4
x
|
11.8
x
|
10.1
x
|
8.4
x
|
Yield
|
-
|
1.77%
|
1.9%
|
2.84%
|
2.38%
|
2.47%
|
2.87%
|
3.4%
|
Capitalization / Revenue
|
0.67
x
|
0.55
x
|
0.5
x
|
0.33
x
|
0.35
x
|
0.45
x
|
0.43
x
|
0.41
x
|
EV / Revenue
|
1.39
x
|
1.31
x
|
1.35
x
|
1.18
x
|
1.16
x
|
1.22
x
|
1.14
x
|
1.03
x
|
EV / EBITDA
|
10.2
x
|
8.73
x
|
8.66
x
|
7.28
x
|
6.78
x
|
6.8
x
|
6.26
x
|
5.61
x
|
EV / FCF
|
-8.8
x
|
12.5
x
|
13.6
x
|
10.3
x
|
9.47
x
|
12.2
x
|
11.1
x
|
9.65
x
|
FCF Yield
|
-11.4%
|
8.03%
|
7.33%
|
9.75%
|
10.6%
|
8.22%
|
9.02%
|
10.4%
|
Price to Book
|
1.84
x
|
1.42
x
|
1.26
x
|
0.89
x
|
0.96
x
|
1.22
x
|
1.12
x
|
1.01
x
|
Nbr of stocks (in thousands)
|
94,505
|
94,437
|
94,302
|
94,533
|
89,563
|
86,563
|
-
|
-
|
Reference price
2 |
78.50
|
65.10
|
60.60
|
44.02
|
52.60
|
72.75
|
72.75
|
72.75
|
Announcement Date
|
2/14/20
|
2/16/21
|
2/9/22
|
2/9/23
|
2/8/24
|
-
|
-
|
-
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net sales
1 |
11,040
|
11,083
|
11,478
|
12,635
|
13,312
|
13,952
|
14,585
|
15,179
|
EBITDA
1 |
1,508
|
1,663
|
1,794
|
2,044
|
2,278
|
2,493
|
2,654
|
2,779
|
EBIT
1 |
525
|
717
|
743
|
843
|
981
|
1,150
|
1,233
|
1,379
|
Operating Margin
|
4.76%
|
6.47%
|
6.47%
|
6.67%
|
7.37%
|
8.24%
|
8.45%
|
9.09%
|
Earnings before Tax (EBT)
1 |
276
|
457
|
297
|
482
|
565
|
682.6
|
797.4
|
960.5
|
Net income
1 |
215
|
359
|
237
|
366
|
455
|
537.7
|
625.9
|
755.8
|
Net margin
|
1.95%
|
3.24%
|
2.06%
|
2.9%
|
3.42%
|
3.85%
|
4.29%
|
4.98%
|
EPS
2 |
2.520
|
3.800
|
2.510
|
3.890
|
5.070
|
6.154
|
7.189
|
8.663
|
Free Cash Flow
1 |
-1,743
|
1,166
|
1,139
|
1,451
|
1,631
|
1,394
|
1,498
|
1,617
|
FCF margin
|
-15.79%
|
10.52%
|
9.92%
|
11.48%
|
12.25%
|
10%
|
10.27%
|
10.65%
|
FCF Conversion (EBITDA)
|
-
|
70.11%
|
63.49%
|
70.99%
|
71.6%
|
55.93%
|
56.43%
|
58.19%
|
FCF Conversion (Net income)
|
-
|
324.79%
|
480.59%
|
396.45%
|
358.46%
|
259.34%
|
239.27%
|
213.94%
|
Dividend per Share
2 |
-
|
1.150
|
1.150
|
1.250
|
1.250
|
1.799
|
2.089
|
2.473
|
Announcement Date
|
2/14/20
|
2/16/21
|
2/9/22
|
2/9/23
|
2/8/24
|
-
|
-
|
-
|
Fiscal Period: December |
2021 Q4
|
2022 Q1
|
2022 Q2
|
2022 Q3
|
2022 Q4
|
2023 Q1
|
2023 Q2
|
2023 Q3
|
2023 Q4
|
2024 Q1
|
2024 Q2
|
2024 Q3
|
2024 Q4
|
2025 Q1
|
2025 Q2
|
---|
Net sales
1 |
2,988
|
3,080
|
3,143
|
3,187
|
3,225
|
3,235
|
3,310
|
3,355
|
3,412
|
3,484
|
3,496
|
3,462
|
3,525
|
3,666
|
3,683
|
EBITDA
1 |
492
|
451
|
511
|
634
|
447
|
510
|
485
|
693
|
591
|
593
|
561.8
|
722.6
|
615.8
|
628
|
623
|
EBIT
1 |
182
|
167
|
202
|
333
|
140
|
191
|
167
|
360
|
264
|
256
|
228.5
|
386.5
|
279
|
289
|
284
|
Operating Margin
|
6.09%
|
5.42%
|
6.43%
|
10.45%
|
4.34%
|
5.9%
|
5.05%
|
10.73%
|
7.74%
|
7.35%
|
6.54%
|
11.16%
|
7.92%
|
7.88%
|
7.71%
|
Earnings before Tax (EBT)
1 |
-49
|
83
|
117
|
249
|
33
|
89
|
59
|
261
|
157
|
140
|
109.9
|
269
|
163.6
|
173
|
169
|
Net income
1 |
-37
|
66
|
86
|
193
|
22
|
70
|
46
|
206
|
133
|
111
|
85.88
|
212.7
|
128.1
|
134
|
132
|
Net margin
|
-1.24%
|
2.14%
|
2.74%
|
6.06%
|
0.68%
|
2.16%
|
1.39%
|
6.14%
|
3.9%
|
3.19%
|
2.46%
|
6.14%
|
3.63%
|
3.66%
|
3.58%
|
EPS
2 |
-0.3900
|
0.7000
|
0.9100
|
2.040
|
0.2400
|
0.7700
|
0.5100
|
2.300
|
1.480
|
1.250
|
0.9803
|
2.438
|
1.472
|
1.550
|
1.520
|
Dividend per Share
2 |
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
2/9/22
|
5/4/22
|
8/18/22
|
11/3/22
|
2/9/23
|
5/4/23
|
8/17/23
|
11/2/23
|
2/8/24
|
5/3/24
|
-
|
-
|
-
|
-
|
-
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net Debt
1 |
7,917
|
8,376
|
9,821
|
10,718
|
10,739
|
10,668
|
10,308
|
9,303
|
Net Cash position
1 |
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Leverage (Debt/EBITDA)
|
5.25
x
|
5.037
x
|
5.474
x
|
5.244
x
|
4.714
x
|
4.279
x
|
3.884
x
|
3.348
x
|
Free Cash Flow
1 |
-1,743
|
1,166
|
1,139
|
1,451
|
1,631
|
1,395
|
1,498
|
1,617
|
ROE (net income / shareholders' equity)
|
6.4%
|
8.59%
|
5.35%
|
7.95%
|
9.48%
|
10.6%
|
12.1%
|
12.6%
|
ROA (Net income/ Total Assets)
|
2.19%
|
2.52%
|
1.51%
|
2.12%
|
2.54%
|
2.96%
|
3.58%
|
4.08%
|
Assets
1 |
9,817
|
14,264
|
15,696
|
17,275
|
17,884
|
18,185
|
17,477
|
18,529
|
Book Value Per Share
2 |
42.70
|
45.80
|
47.90
|
49.70
|
54.80
|
59.50
|
64.70
|
71.90
|
Cash Flow per Share
|
11.40
|
13.60
|
12.80
|
15.30
|
-
|
-
|
-
|
-
|
Capex
1 |
111
|
112
|
131
|
105
|
90
|
122
|
134
|
140
|
Capex / Sales
|
1.01%
|
1.01%
|
1.14%
|
0.83%
|
0.68%
|
0.88%
|
0.92%
|
0.92%
|
Announcement Date
|
2/14/20
|
2/16/21
|
2/9/22
|
2/9/23
|
2/8/24
|
-
|
-
|
-
|
Last Close Price
72.75
SEK Average target price
82.67
SEK Spread / Average Target +13.63% Consensus |
1st Jan change
|
Capi.
|
---|
| +37.93% | 597M | | +24.66% | 88.38B | | -21.76% | 77.56B | | +6.97% | 28.74B | | +7.41% | 18.45B | | -13.50% | 16.57B | | +77.51% | 13.65B | | +76.96% | 13.06B | | +4.45% | 12.61B | | +36.67% | 12.56B |
Other Healthcare Facilities & Services
|